These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


461 related items for PubMed ID: 38026539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multifunctional MnO2/Ag3SbS3 Nanotheranostic Agent for Single-Laser-Triggered Tumor Synergistic Therapy in the NIR-II Biowindow.
    Wang Q, Qu B, Li J, Liu Y, Dong J, Peng X, Zhang R.
    ACS Appl Mater Interfaces; 2022 Feb 02; 14(4):4980-4994. PubMed ID: 35050589
    [Abstract] [Full Text] [Related]

  • 4. Tumor microenvironment activated mussel-inspired hollow mesoporous nanotheranostic for enhanced synergistic photodynamic/chemodynamic therapy.
    Tian Yan H, Jang MS, Liu C, Fu Q, Wang B, Fu Y, Hee Lee J, Yu Yang H.
    J Colloid Interface Sci; 2024 Jul 02; 665():188-203. PubMed ID: 38522159
    [Abstract] [Full Text] [Related]

  • 5. Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy.
    Chen M, Zhao S, Zhu J, Feng E, Lv F, Chen W, Lv S, Wu Y, Peng X, Song F.
    ACS Appl Mater Interfaces; 2022 May 11; 14(18):20682-20692. PubMed ID: 35500204
    [Abstract] [Full Text] [Related]

  • 6. Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy.
    Liang J, Sun Y, Wang K, Zhang Y, Guo L, Bao Z, Wang D, Xu H, Zheng J, Yuan Y.
    ACS Appl Mater Interfaces; 2023 Apr 12; 15(14):18191-18204. PubMed ID: 36975190
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu9S5 nanozymes.
    Zhou Z, Gao Z, Chen W, Wang X, Chen Z, Zheng Z, Chen Q, Tan M, Liu D, Zhang Y, Hou Z.
    Acta Biomater; 2022 Oct 01; 151():600-612. PubMed ID: 35953045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cu2+-pyropheophorbide-a-cystine conjugate-mediated multifunctional mesoporous silica nanoparticles for photo-chemodynamic therapy/GSH depletion combined with immunotherapy cancer.
    Xu H, Su Z, Zhang H, Zhang Y, Bao Y, Zhang H, Wu X, Yan R, Wang Z, Jin Y.
    Int J Pharm; 2023 Jun 10; 640():123002. PubMed ID: 37254284
    [Abstract] [Full Text] [Related]

  • 13. Near-infrared light-triggered synergistic antitumor therapy based on hollow ZIF-67-derived Co3S4-indocyanine green nanocomplex as a superior reactive oxygen species generator.
    Jiang Y, Lu Y, Lei L, Zhou S, Yang L, Yang X, Xu Z, Liu J, Liu Y.
    Mater Sci Eng C Mater Biol Appl; 2021 Nov 10; 130():112465. PubMed ID: 34702540
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Covalent organic frameworks-derived carbon nanospheres based nanoplatform for tumor specific synergistic therapy via oxidative stress amplification and calcium overload.
    Pang Y, Lv J, He C, Ju C, Lin Y, Zhang C, Li M.
    J Colloid Interface Sci; 2024 May 10; 661():908-922. PubMed ID: 38330663
    [Abstract] [Full Text] [Related]

  • 17. Lonidamine liposomes to enhance photodynamic and photothermal therapy of hepatocellular carcinoma by inhibiting glycolysis.
    Lei L, Dai W, Man J, Hu H, Jin Q, Zhang B, Tang Z.
    J Nanobiotechnology; 2023 Dec 15; 21(1):482. PubMed ID: 38102658
    [Abstract] [Full Text] [Related]

  • 18. A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy.
    Su Z, Xu H, Zhang Y, Zhang H, Zhang H, Bao Y, Wu X, Yan R, Tan G, Wang Z, Jin Y.
    J Mater Chem B; 2023 May 17; 11(19):4211-4226. PubMed ID: 37114499
    [Abstract] [Full Text] [Related]

  • 19. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
    Zhang L, Fan Y, Yang Z, Yang M, Wong CY.
    J Nanobiotechnology; 2021 Sep 06; 19(1):265. PubMed ID: 34488803
    [Abstract] [Full Text] [Related]

  • 20. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor.
    Zhang Y, Hu H, Deng X, Song Q, Xing X, Liu W, Zhang Y.
    Int J Nanomedicine; 2022 Sep 06; 17():5491-5510. PubMed ID: 36438608
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.